Cargando…
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors
Identifying novel genes that drive tumor metastasis and drug resistance has significant potential to improve patient outcomes. High-throughput sequencing approaches have identified cancer genes, but distinguishing driver genes from passengers remains challenging. Insertional mutagenesis screens usin...
Autores principales: | Bii, Victor M., Trobridge, Grant D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126759/ https://www.ncbi.nlm.nih.gov/pubmed/27792127 http://dx.doi.org/10.3390/cancers8110099 |
Ejemplares similares
-
Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes
por: Bii, Victor M., et al.
Publicado: (2018) -
A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis
por: Rae, Dustin T., et al.
Publicado: (2015) -
Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy
por: Browning, Diana L., et al.
Publicado: (2016) -
A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker
por: Bii, Victor M., et al.
Publicado: (2015) -
A novel approach to identify driver genes involved in androgen-independent prostate cancer
por: Schinke, Ellyn N, et al.
Publicado: (2014)